Immunotherapy Today

Immunotherapy News From Around The World

< Immunotherapy Today home

Author: btwatson

Immunotherapy Response in Mesohtelioma: PARP Inhibitors May Help – Surviving Mesothelioma
Past, Present and Future: 'Immunotherapy is Here to Stay' – Curetoday.com
FDA approves first immunotherapy drug for breast cancer – Medical Xpress
FDA Approves 1st Immunotherapy Breast Cancer Drug – WebMD

Tecentriq Approved As First Immunotherapy for Breast Cancer – Managed Care magazine
Lead analyst says: “Global cancer immunotherapy market set to grow to $117bn by 2024”. – GlobeNewswire
Unique Immunotherapy Combinations Provide an Optimistic Outlook in Early Urothelial Carcinoma… – Targeted Oncology

Rizvi Highlights Impact of Immunotherapy and Next Steps NSCLC – OncLive
PARP Inhibitors May Enhance Immunotherapy Response in Lung Cancer – Specialty Pharmacy Times
FDA Approves 1st Immunotherapy Breast Cancer Drug – WebMD

< Newer Entries | Older Entries >

Copyright 2018 ImmunoTherapyToday.com